Ranson M - Search Results

1

Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.

Danson S, Middleton MR, O'Byrne KJ, Clemons M, Ranson M, Hassan J, Anderson H, Burt PA, Fairve-Finn C, Stout R, Dowd I, Ashcroft L, Beresford C, Thatcher N. Danson S, et al. Among authors: ranson m. Cancer. 2003 Aug 1;98(3):542-53. doi: 10.1002/cncr.11535. Cancer. 2003. PMID: 12879472 Free article. Clinical Trial.

2

Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.

Kamthan AG, Lind MJ, Thatcher N, Steward WP, Bronchud MH, Ranson MR, Stout R. Kamthan AG, et al. Among authors: ranson mr. Eur J Cancer. 1990;26(6):691-4. doi: 10.1016/0277-5379(90)90118-d. Eur J Cancer. 1990. PMID: 2168191

3

Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.

Prendiville J, Radford J, Thatcher N, Steward W, Ranson M, Burt P, Stout R. Prendiville J, et al. Among authors: ranson m. J Clin Oncol. 1991 Aug;9(8):1446-52. doi: 10.1200/JCO.1991.9.8.1446. J Clin Oncol. 1991. PMID: 1649266

4

Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study.

Betticher DC, Anderson H, Ranson M, Meely K, Oster W, Thatcher N. Betticher DC, et al. Among authors: ranson m. Br J Cancer. 1995 Dec;72(6):1551-5. doi: 10.1038/bjc.1995.546. Br J Cancer. 1995. PMID: 8519676 Free PMC article. Clinical Trial.

5

Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: changes in performance status and tumour-related symptoms.

Thatcher N, Anderson H, Betticher DC, Ranson M. Thatcher N, et al. Among authors: ranson m. Anticancer Drugs. 1995 Dec;6 Suppl 6:39-48. doi: 10.1097/00001813-199512006-00007. Anticancer Drugs. 1995. PMID: 8718424 Review.

6

The importance of dose and schedule in chemotherapy for small cell lung cancer.

Ranson M, Thatcher N. Ranson M, et al. Anticancer Drugs. 1995 Oct;6 Suppl 5:53-63. doi: 10.1097/00001813-199510005-00006. Anticancer Drugs. 1995. PMID: 8845495 Review.

7

Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer.

Thatcher N, Jayson G, Bradley B, Ranson M, Anderson H. Thatcher N, et al. Among authors: ranson m. Semin Oncol. 1997 Jun;24(3 Suppl 8):S8-6-S8-12. Semin Oncol. 1997. PMID: 9207309 Review.

8

Phase II study of oral topotecan in advanced non-small cell lung cancer.

White SC, Cheeseman S, Thatcher N, Anderson H, Carrington B, Hearn S, Ross G, Ranson M. White SC, et al. Among authors: ranson m. Clin Cancer Res. 2000 Mar;6(3):868-73. Clin Cancer Res. 2000. PMID: 10741709 Clinical Trial.

9

Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma.

White SC, Anderson H, Jayson GC, Ashcroft L, Ranson M, Thatcher N. White SC, et al. Among authors: ranson m. Ann Oncol. 2000 Feb;11(2):201-6. doi: 10.1023/a:1008328605413. Ann Oncol. 2000. PMID: 10761756 Free article. Clinical Trial.

10

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

Ranson M, Davidson N, Nicolson M, Falk S, Carmichael J, Lopez P, Anderson H, Gustafson N, Jeynes A, Gallant G, Washington T, Thatcher N. Ranson M, et al. J Natl Cancer Inst. 2000 Jul 5;92(13):1074-80. doi: 10.1093/jnci/92.13.1074. J Natl Cancer Inst. 2000. PMID: 10880550 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters